NFJ Investment Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-3,461
Closed -$586K – 293
2022
Q4
$586K Sell
3,461
-72,013
-95% -$13.1M 0.02% 265
2022
Q3
$14.4M Sell
75,474
-55,400
-42% -$11.7M 0.37% 90
2022
Q2
$21.3M Sell
130,874
-387
-0.3% -$61.2K 0.51% 66
2022
Q1
$24.7M Buy
131,261
+77,331
+143% +$14.7M 0.5% 64
2021
Q4
$14.3M Buy
+53,930
New +$14.5M 0.26% 124

Other funds holding RGEN

NFJ Investment Group's RGEN Position: Q1 2023 in Review

NFJ Investment Group sold out of Repligen (RGEN) in Q1 2023, closing a stake of 3,461 shares — an estimated $586K sold.

NFJ Investment Group first reported a position in RGEN in Q4 2021 and held it in 5 quarters. The position peaked at $24.7M in Q1 2022. 447 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • NFJ Investment Group reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • NFJ Investment Group sold 3,461 Repligen shares in Q1 2023, an estimated $586K.
  • NFJ Investment Group first reported a position in Repligen in Q4 2021 and held it in 5 quarters.
  • NFJ Investment Group's Repligen position peaked at $24.7M in Q1 2022.
  • 447 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on NFJ Investment Group's 13F filing for Q1 2023, filed 15 May 2023.